About

Moebius Medical is an innovative clinical-stage biotech company that leverages its proprietary liposomal technologies and related expertise for the development of novel products.

We were founded in 2008 within the RAD Biomed Accelerator to commercialize a patent-protected liposomal technology licensed from the Hebrew University of Jerusalem, the Technion Institute and Hadassah Medical Center. Our goal is to leverage our liposome technological expertise, our proven experience in the development of drugs and medical devices, and our deep understanding of joint lubrication and cartilage regeneration to bring innovative products to market that answer unmet medical needs. To date, our main focus has been the development of a novel treatment for osteoarthritis, which is currently in clinical trials.

We are differentiated by our years of expertise and demonstrated success in the development of both drugs and medical devices. For musculoskeletal conditions, our unique know-how and experience in osteoarthritis and the cartilage field has facilitated successful navigation of regulatory hurdles, moving us from early R&D through pre-clinical safety and efficacy studies to reach clinic. On the manufacturing and analytical side, we benefit from our proven expertise in the development of liposomal technologies, including the challenging aseptic manufacturing processes and complex analytical methods associated with the testing of liposomal products.

  • Management
  • Board of Directors
Moshe Weinstein
CEO
Dr. Ronny Pinkus
VP Manufacturing & Operations
Dr. Roni (Aharon) Wechsler
Head of Research
Dr. Gadi Sarfati
Senior Director
Mr. Uri Ben-Or
Prof. Nava Zisapel
Co-Founder and Chairperson of RAD Biomed
Prof. Chezy Barenholz
Inventor & Board Member
Bob Trachtenberg
General Counsel of Yissum
David Zigdon
CEO of MIGAL Galilee Research Institute

Moshe Weinstein, MBA

CEO

Moshe joined Moebius in December 2015, and brings with him over 15 years of business experience. Prior to joining Moebius, Moshe spent 7 years at Novartis in the US and Latin America where he held positions of increasing responsibility in business development & licensing, sales, marketing and commercial management. Prior to Novartis, Moshe served as a consultant for Price water house Coopers. Moshe also serves as executive chairman of Everads Therapy Ltd, a company developing a novel delivery system for ophthalmic therapies.Moshe earned an MBA from INSEAD, and has a bachelors in business & management from Yeshiva University in New York.

Moshe Weinstein
CEO
Dr. Ronny Pinkus
VP Manufacturing & Operations
Dr. Roni (Aharon) Wechsler
Head of Research
Dr. Gadi Sarfati
Senior Director
Mr. Uri Ben-Or
Prof. Nava Zisapel
Co-Founder and Chairperson of RAD Biomed
Prof. Chezy Barenholz
Inventor & Board Member
Bob Trachtenberg
General Counsel of Yissum
David Zigdon
CEO of MIGAL Galilee Research Institute